Zomedica Pharmaceuticals Corp. [NYSE: ZOM] opened at $0.26 and closed at $0.25 a share within trading session on 13/06/2019. That means that the stock gained by 10.20% compared to the closing price from a day before, when the stock touched $0.27.
Between the start and the closing of the latest trading session, Zomedica Pharmaceuticals Corp. [NYSE: ZOM] had 5.96 million shares being bought and sold. In the last three months, average trading volumes hovered around 238.19K shares. During the last week, volatility in the share price was set at 28.14%, which placed the metric for the last 30 days at 16.32%. The price of the stock additionally went down to $0.20 during that period and ZOM managed to take a rebound to $2.98 in the last 52 weeks.
Zomedica Pharmaceuticals Corp. [NYSE:ZOM]: Analyst Rating and Earnings
Stock traders often pay close attention what Wall Street analysts have to say about a potential investment. For Zomedica Pharmaceuticals Corp. [ZOM], the latest consensus recommendation available followed its financial results for the fiscal quarter ending in December. On average, stock market experts give ZOM an Outperform rating. Its stock price has been found in the range of 0.20 to 2.98. This is compared to its latest closing price of $0.25.
Keep an eye out for the next scheduled publication date for this company’s financial results, which are expected to be released on Thu 8 Aug (In 55 Days).
Fundamental Analysis of Zomedica Pharmaceuticals Corp. [ZOM]
What about valuation? This company’s Enterprise Value to EBITDA is -9.89. Zomedica Pharmaceuticals Corp. [ZOM] has a Price to Book Ratio of 23.02.
This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.83 and its Current Ratio is 4.83. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Zomedica Pharmaceuticals Corp. [ZOM] has 110.32M shares outstanding, amounting to a total market cap of $29.80M. Its stock price has been found in the range of 0.20 to 2.98. At its current price, it has moved down by -90.94% from its 52-week high, and it has moved up 35.32% from its 52-week low.
This stock’s Beta value is currently , which indicates that it is 28.14% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 44.67. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Zomedica Pharmaceuticals Corp. [ZOM] a Reliable Buy?
Zomedica Pharmaceuticals Corp. [ZOM] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.